Compare Ginkgo Bioworks Holdings Inc (DNA) vs Five9 Inc (FIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Five9 Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.27 (market cap $485.52M), while Five9 Inc trades at $33.74 (market cap $2.33B). The key difference: Five9 Inc is far larger — about 4.8× Ginkgo Bioworks Holdings Inc's market cap, and Five9 Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | FIVN | |
|---|---|---|
Market Cap | $485.52M | $2.33B |
Sector | Health | Technology |
52-Week High | $16.14 | $34.48 |
52-Week Low | $5.48 | $13.61 |
Enterprise Value | $587.47M | $2.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →
